11 annotations
Investments and intangible assets2,143.4 1,001.4
the main source of deferred tax liability
10-K
2020 FY
13 Mar 21
(c) Equity securities are included in the following accounts in the consolidated balance sheets (in millions):December 31, 2020December 31, 2019Short-term investments$61.4 $51.0 Other investments9,521.0 4,613.4 Total$9,582.4 $4,664.4 The change in fair market value on our equity securities for the year ended December 31, 2020 was $4,495.8 million gain, which was primarily due to our investment in Sartorius AG and is recorded in our consolidated statements of income.63As of December 31, 2020, we own 12,987,900 ordinary voting shares and 9,588,908 preference shares of Sartorius AG (Sartorius), of Goettingen, Germany, a process technology supplier to the biotechnology, pharmaceutical, chemical and food and beverage industries. We did not purchase any incremental shares for the years ended December 31, 2020 and 2019. We own approximately 37% of the ordinary outstanding voting shares (excluding treasury shares) and 28% of the preference shares of Sartorius as of December 31, 2020. The Sartorius family trust and Sartorius family members hold a controlling interest of the outstanding voting shares. We do not have any representative or designee on Sartorius' board of directors, nor do we have the ability to exercise significant influence over the operating and financial policies of Sartorius.
Details on ownership in Sartorius AG that is responsible for a large portion of the earnings of Bio-Rad
10-K
2020 FY
13 Mar 21
Net increase in cash, cash equivalents and restricted cash
(No comment added)
10-K
2020 FY
13 Mar 21
Net cash used in financing activities
(No comment added)
10-K
2020 FY
13 Mar 21
Other comprehensive income (loss), net of tax
(No comment added)
10-K
2020 FY
13 Mar 21
Change in fair market value of equity securities
(No comment added)
10-K
2020 FY
13 Mar 21
Retained earnings9,268,012 5,470,779
(No comment added)
10-K
2020 FY
13 Mar 21
2,076,785 997,787
lots of deferred taxes
10-K
2020 FY
13 Mar 21
131,102 86,840
increased current liabilities
10-K
2020 FY
13 Mar 21
1,798 426,172
most of the long term debt paid
10-K
2020 FY
13 Mar 21
Other investments9,561,140 4,638,205
high growth in other investments
10-K
2020 FY
13 Mar 21
- Prev
- 1
- Next